FDA Warns Hospira Again For Poor Practices In Italy
Hospira Inc. said Tuesday that it is investigating claims of drug manufacturing problems at its Italy plant that were outlined in a U.S. Food and Drug Administration warning letter....To view the full article, register now.
Already a subscriber? Click here to view full article